Corvus Pharmaceuticals, Inc. Soared

Mon, Sep 20, 2021 at 05:30 PM
Corvus Pharmaceuticals, Inc. Soared

Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) shot up at $6.17, a gain of 16%. On Fri, Sep 17, 2021, CRVS:NASDAQ hit a New 2-Week High of $5.32. The stock got featured on our News Catalysts scanner on Sun, Sep 19, 2021 at 12:03 PM in the 'BIOTECH' category. From Fri, Sep 03, 2021, the stock recorded 44.44% Up Days and 30.00% Green Days

About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.